Boston Scientific Acquires Lumenis Surgical Business from Baring Private Equity Asia for $1.07B
March 3, 2021
Boston Scientific has agreed to acquire the Lumenis Surgical Business from Baring Private Equity Asia/Lumenis for USD 1.07 billion, subject to closing adjustments. The deal transfers Lumenis' surgical laser portfolio and global surgical team (including its Israeli laser center of excellence) to Boston Scientific to bolster its Urology strategy, while Lumenis — still owned by BPEA — will focus on Aesthetics and Vision.
- Buyers
- Boston Scientific
- Targets
- Lumenis Surgical Business
- Sellers
- Baring Private Equity Asia, Lumenis
- Industry
- Medical Devices
- Location
- Israel
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Boston Scientific Acquires Baylis Medical Company Inc.
October 6, 2021
Medical Devices
Boston Scientific Corporation agreed to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition expands Boston Scientific’s electrophysiology and structural heart portfolios by adding Baylis’s RF NRG and VersaCross transseptal platforms and complementary guidewires, sheaths and dilators; Baylis was expected to generate nearly $200 million in net sales in 2022.
-
Boston Scientific Acquires BTG plc
August 19, 2019
Medical Devices
Boston Scientific Corporation completed its acquisition of BTG plc by scheme of arrangement, with BTG shareholders receiving 840 pence in cash per share. The purchase brings BTG’s interventional medicine portfolio, specialty pharmaceuticals and licensing business into Boston Scientific, strengthening its capabilities in interventional oncology and vascular therapies.
-
Microsoft Acquires Lumenisity
December 15, 2022
Telecommunications
Microsoft has acquired Lumenisity, a U.K. pioneer in hollow-core optical fiber (NANF) technology, following Lumenisity's completion of a new hollow-core fiber manufacturing facility in the United Kingdom. The acquisition is intended to accelerate Microsoft's efforts to reduce latency and increase data throughput across its cloud and distributed computing infrastructure, with potential applications across telecom, finance and healthcare.
-
Caldera Medical Acquires UVision 360 and the LUMINELLE Product Family
October 8, 2024
Medical Devices
Caldera Medical has acquired UVision 360, the developer of the LUMINELLE hysteroscopy and cystoscopy systems, expanding its minimally invasive women's health device portfolio. The deal brings the LUMINELLE product family — including the new LUMINELLE Bx on-demand biopsy technology — into Caldera's commercial infrastructure to broaden office-based and surgical hysteroscopy capabilities.
-
Bausch + Lomb Acquires Elios Vision
December 11, 2024
Medical Devices
Bausch + Lomb Corporation (through an affiliate) has acquired Elios Vision, Inc., developer of the ELIOS excimer-laser MIGS system, expanding Bausch + Lomb's glaucoma surgical capabilities and complementing its cataract surgery portfolio. The ELIOS technology, currently CE marked and marketed in the EU, is undergoing pursuit of FDA approval and will be commercialized more broadly through Bausch + Lomb's global cataract surgery channels.
-
Boston Scientific Acquires Axonics, Inc.
November 15, 2024
Medical Devices
Boston Scientific Corporation agreed to and completed the acquisition of Axonics, Inc., a publicly traded medical technology company focused on sacral neuromodulation and urology devices, for $71 per share (approximately $3.7 billion equity value). The deal expands Boston Scientific’s urology portfolio by adding Axonics’ SNM therapy products and related technologies, expected to be accretive to its Urology business over time.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.